13/10/2026
💗 New hope for hard-to-treat breast cancers.
TRI-based Associate Professor Fernando Guimaraes and his research team from UQ Health have developed a novel antibody that guides the body's natural killer cells to seek out and destroy hard-to-treat tumours, including triple-negative breast cancer.
Using engineered "super" immune cells, the team has shown promising results in preclinical studies, paving the way for new immunotherapy treatments with fewer side effect, better outcomes for patients, and potential clinical trials.
The University of Queensland